In myeloma cells, IL-6 triggers cell proliferation via at least two intracellular signaling pathways, including JAK/STAT3[6] [7] [8], and the ras-dependent mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) cascade [8–10]. This evidence concerns the gene IL6 and plasma cell myeloma.